Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Acadia Healthcare Company Inc (NASDAQ: ACHC) closed the day trading at $21.74 down -5.35% from the previous closing price of $22.97. In other words, the price has decreased by -$5.35 from its previous closing price. On the day, 1.63 million shares were traded. ACHC stock price reached its highest trading level at $23.01 during the session, while it also had its lowest trading level at $21.74.
Ratios:
For a better understanding of ACHC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.34 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.75.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Barclays on February 28, 2025, Downgraded its rating to Equal Weight and sets its target price to $35 from $43 previously.
On January 07, 2025, KeyBanc Capital Markets Upgraded its rating to Overweight which previously was Sector Weight but kept the price unchanged to $70.
Deutsche Bank Upgraded its Hold to Buy on December 12, 2024, whereas the target price for the stock was revised from $45 to $75.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 30 ’24 when Hollinsworth John S. bought 20,000 shares for $53.02 per share.
Hollinsworth John S. bought 10,000 shares of ACHC for $812,065 on Aug 29 ’24. On Aug 08 ’24, another insider, Hollinsworth John S., who serves as the Officer of the company, bought 5,000 shares for $71.57 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHC now has a Market Capitalization of 2002736640 and an Enterprise Value of 4395408896. As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.67, and their Forward P/E ratio for the next fiscal year is 7.40. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.63 while its Price-to-Book (P/B) ratio in mrq is 0.65. Its current Enterprise Value per Revenue stands at 1.393 whereas that against EBITDA is 6.953.
Stock Price History:
The Beta on a monthly basis for ACHC is 0.89, which has changed by -0.67352456 over the last 52 weeks, in comparison to a change of 0.16564083 over the same period for the S&P500. Over the past 52 weeks, ACHC has reached a high of $82.40, while it has fallen to a 52-week low of $20.35. The 50-Day Moving Average of the stock is -5.26%, while the 200-Day Moving Average is calculated to be -36.60%.
Shares Statistics:
Over the past 3-months, ACHC traded about 2.13M shares per day on average, while over the past 10 days, ACHC traded about 1349100 shares per day. A total of 92.12M shares are outstanding, with a floating share count of 90.49M. Insiders hold about 1.78% of the company’s shares, while institutions hold 109.01% stake in the company. Shares short for ACHC as of 1752537600 were 10595146 with a Short Ratio of 5.19, compared to 1749772800 on 9300639. Therefore, it implies a Short% of Shares Outstanding of 10595146 and a Short% of Float of 13.370000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The dynamic stock of Acadia Healthcare Company Inc (ACHC) is currently attracting attention from 13.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.85, with high estimates of $0.99 and low estimates of $0.63.
Analysts are recommending an EPS of between $2.78 and $2.37 for the fiscal current year, implying an average EPS of $2.62. EPS for the following year is $2.95, with 14.0 analysts recommending between $3.26 and $2.41.
Revenue Estimates
13 analysts predict $841M in revenue for the current quarter. It ranges from a high estimate of $860.75M to a low estimate of $825M. As of the current estimate, Acadia Healthcare Company Inc’s year-ago sales were $796.04MFor the next quarter, 13 analysts are estimating revenue of $877.38M. There is a high estimate of $893.35M for the next quarter, whereas the lowest estimate is $856.9M.
A total of 13 analysts have provided revenue estimates for ACHC’s current fiscal year. The highest revenue estimate was $3.36B, while the lowest revenue estimate was $3.3B, resulting in an average revenue estimate of $3.34B. In the same quarter a year ago, actual revenue was $3.15BBased on 13 analysts’ estimates, the company’s revenue will be $3.62B in the next fiscal year. The high estimate is $3.68B and the low estimate is $3.53B.
